GEODE CAPITAL MANAGEMENT, LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1214717
BOSTON, MA
Position in XERS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$37,368,008
+$12,482,360 QoQ
Shares Held
4,718,183
+10.0% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 238 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. XERS ranks #21 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in XERS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,368,008 | 4,718,183 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $24,885,648 | 4,290,629 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,566,513 | 4,275,989 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $33,701,016 | 4,140,174 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $17,048,712 | 3,650,688 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $18,697,984 | 3,405,826 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,361,333 | 3,351,426 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,500,388 | 3,333,470 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,290,852 | 3,240,379 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $6,730,254 | 3,045,364 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,796,380 | 2,892,077 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,158,324 | 2,773,293 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,026,329 | 2,681,805 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,125,049 | 2,530,705 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,235,505 | 2,432,711 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,670,714 | 2,353,022 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,347,273 | 2,173,554 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,974,438 | 1,161,890 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,944,650 | 1,005,000 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,725,216 | 704,170 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||